Multi-Vitamin Elite P.M. (90 capsules) by Thorne

PM Formula: Enhances rest and recovery*
– Contains Relora®, a proprietary blend of Magnolia and Phellodendron extracts
– Relora down-regulates evening cortisol levels that can cause anxious feelings and interfere with weight management efforts*
– Relora has been shown to curb late-night cravings and, coupled with the extra magnesium, supports restful sleep*
– In one trial, athletes who took Multi-Vitamin Elite P.M. fell asleep faster and achieved better sleep quality*

Take 3 capsules in the evening daily with a meal.

Serving Size: 3 Capsules

Amount Per Serving
Magnolia officinalis Bark Extract … 18.3 mg
Standardized to 8.5% honokiol
Phellodendron amurense  Bark Extract … 6.1 mg
Standardized to 2.5% berberine
Vitamin C (Ascorbic Acid) … 50 mg
Magnesium (Magnesium Bisglycinate) (TRAACS®) … 35.7 mg
Calcium (Calcium Bisglycinate) (TRAACS®) … 16.7 mg
Choline (Choline Dihydrogen Citrate) … 11.9 mg
D-gamma-Tocopherol (Mixed Tocopherol concentrate) … 8 mg
Zinc (Zinc Bisglycinate) (TRAACS®) … 6.7 mg
Vitamin E (d-Alpha-Tocopheryl Acid Succinate) (6.7 IU) … 4.5 mg AT
Boron (Boron Glycinate) (Bororganic)…. 667 mcg
Manganese (Manganese (II) Bisglycinate) (TRAACS®) … 500 mcg
Copper (Copper (II) Bisglycinate) (TRAACS®) … 250 mcg Lutein (oleoresin of Tagetes erecta L. (Asteraceae)) … 200 mcg
Biotin … 167 mcg
Folate (L-5-Methyltetrahydrofolic Acid, Glucosamine Salt) … 134 mcg
Beta-carotene (all-trans-beta-carotene) (200 IU) … 120 mcg Chromium (Chromium (III) Nicotinate Glycinate) (TRAACS®) … 67 mcg
Vitamin A (Vitamin A Palmitate) (134 IU) … 40.5 mcg RAE Vitamin K1 … 34 mcg
Vitamin K2 … 34 mcg
Selenium (Selenomethionine) … 34 mcg
Iodine (Potassium Iodide) … 25 mcg
Molybdenum (Molybdenum (VI) Bisglycinate) (TRAACS®) … 16.7 mcg
Vitamin D3 (Cholecalciferol) (167 IU) … 4.2 mcg

PREGNANCY WARNING If pregnant or nursing, do not use this product; otherwise consult your health professional before using this product.

INTERACTIONS/CONTRAINDICATIONS Because vitamin K interferes with the effect of anticoagulant drugs (like Coumadin), the concurrent use of these agents should be avoided. 5-methyltetrahydrofolate supplementation is not recommended concurrently with methotrexate cancer therapy because they can interfere with methotrexate’s anti-neoplastic activity; however, this folate source has not been shown to interfere with the anti-inflammatory activity of methotrexate. Therefore, an individual taking methotrexate for psoriasis or rheumatoid arthritis can safely take a supplement containing folate. Curcumin has been shown to reduce the therapeutic efficacy of cyclophosphamide (Cytoxan) in animal studies. In vitro research reveals that curcumin decreases camptothecin-induced death of cultured breast cancer cells. Curcumin might also interfere with the absorption and efficacy of the chemotherapy drug irinotecan, used to treat colon cancer. The concurrent use of curcumin with these agents should be avoided.